Anti-inflammatory effects of the hydroxycarboxylic acid receptor 2

Metabolism: Clinical and Experimental

Volumn 65, Issue 2, 2016, Pages 102-113

  Graff, Emily C ^a   Fang, Han ^a   Wanders, Desiree ^b   Judd, Robert L ^a  

^a AUBURN UNIVERSITY   (United States)

^b GEORGIA STATE UNIVERSITY   (United States)

Author keywords

Beta Hydroxybutyrate; GPR109a; HCA2; Inflammation; Niacin

Indexed keywords

G PROTEIN COUPLED RECEPTOR; HYDROXYCARBOXYLIC ACID RECEPTOR 2; UNCLASSIFIED DRUG; HCAR2 PROTEIN, HUMAN; NICOTINIC ACID; NICOTINIC RECEPTOR;

ADIPOSE TISSUE; ANTIINFLAMMATORY ACTIVITY; ATHEROSCLEROSIS; COLITIS; DEGENERATIVE DISEASE; DIABETIC RETINOPATHY; HUMAN; INFLAMMATION; MALIGNANT NEOPLASTIC DISEASE; MICROGLIA; NONHUMAN; OBESITY; PRIORITY JOURNAL; RETINA PIGMENT CELL; REVIEW; ANIMAL; MOUSE; NEOPLASMS; NEURODEGENERATIVE DISEASES; PHYSIOLOGY;

ANIMALS; ATHEROSCLEROSIS; COLITIS; DIABETIC RETINOPATHY; HUMANS; INFLAMMATION; MICE; NEOPLASMS; NEURODEGENERATIVE DISEASES; NIACIN; OBESITY; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NICOTINIC;

EID: 84959518014     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2015.10.001     Document Type: Review

References (119)

1. C.C. Blad, K. Ahmed, IJzerman A.P., and S. Offermanns Biological and pharmacological roles of HCA receptors Adv Pharmacol 62 2011 219 250
2. S. Offermanns, S.L. Colletti, T.W. Lovenberg, G. Semple, A. Wise, and IJzerman A.P. International Union of Basic and Clinical Pharmacology. LXXXII: nomenclature and classification of hydroxy-carboxylic acid receptors (GPR81, GPR109A, and GPR109B) Pharmacol Rev 63 2011 269 290
3. K. Ahmed Biological roles and therapeutic potential of hydroxy-carboxylic acid receptors Front Endocrinol (Lausanne) 2 2011 51
4. D. Wanders, E.C. Graff, B.D. White, and R.L. Judd Niacin increases adiponectin and decreases adipose tissue inflammation in high fat diet-fed mice PLoS One 8 2013 e71285
5. M. Lukasova, C. Malaval, A. Gille, J. Kero, and S. Offermanns Nicotinic acid inhibits progression of atherosclerosis in mice through its receptor GPR109A expressed by immune cells J Clin Invest 121 2011 1163 1173
6. J. Hanson, A. Gille, S. Zwykiel, M. Lukasova, B.E. Clausen, K. Ahmed, and et al. Nicotinic acid- and monomethyl fumarate-induced flushing involves GPR109A expressed by keratinocytes and COX-2-dependent prostanoid formation in mice J Clin Invest 120 2010 2910 2919
7. D. Maciejewski-Lenoir, J.G. Richman, Y. Hakak, I. Gaidarov, D.P. Behan, and D.T. Connolly Langerhans cells release prostaglandin D2 in response to nicotinic acid J Invest Dermatol 126 2006 2637 2646
8. H. Tang, J.Y. Lu, X. Zheng, Y. Yang, and J.D. Reagan The psoriasis drug monomethylfumarate is a potent nicotinic acid receptor agonist Biochem Biophys Res Commun 375 2008 562 565
9. T. Soga, M. Kamohara, J. Takasaki, S. Matsumoto, T. Saito, T. Ohishi, and et al. Molecular identification of nicotinic acid receptor Biochem Biophys Res Commun 303 2003 364 369
10. S. Tunaru, J. Kero, A. Schaub, C. Wufka, A. Blaukat, K. Pfeffer, and et al. PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect Nat Med 9 2003 352 355
11. A. Wise, S.M. Foord, N.J. Fraser, A.A. Barnes, N. Elshourbagy, M. Eilert, and et al. Molecular identification of high and low affinity receptors for nicotinic acid J Biol Chem 278 2003 9869 9874
12. A. Schaub, A. Futterer, and K. Pfeffer PUMA-G, an IFN-gamma-inducible gene in macrophages is a novel member of the seven transmembrane spanning receptor superfamily Eur J Immunol 31 2001 3714 3725
13. S. Elangovan, R. Pathania, S. Ramachandran, S. Ananth, R.N. Padia, L. Lan, and et al. The niacin/butyrate receptor GPR109A suppresses mammary tumorigenesis by inhibiting cell survival Cancer Res 74 2014 1166 1178
14. D. Gambhir, S. Ananth, R. Veeranan-Karmegam, S. Elangovan, S. Hester, E. Jennings, and et al. GPR109A as an anti-inflammatory receptor in retinal pigment epithelial cells and its relevance to diabetic retinopathy Invest Ophthalmol Vis Sci 53 2012 2208 2217
15. M. Rahman, S. Muhammad, M.A. Khan, H. Chen, D.A. Ridder, H. Müller-Fielitz, and et al. The β-hydroxybutyrate receptor HCA2 activates a neuroprotective subset of macrophages Nat Commun 5 2014 1 15
16. G. Kostylina, D. Simon, M.F. Fey, S. Yousefi, and H.U. Simon Neutrophil apoptosis mediated by nicotinic acid receptors (GPR109A) Cell Death Differ 15 2008 134 142
17. X. Li, J.S. Millar, N. Brownell, F. Briand, and D.J. Rader Modulation of HDL metabolism by the niacin receptor GPR109A in mouse hepatocytes Biochem Pharmacol 80 2010 1450 1457
18. H. Ge, J. Weiszmann, J.D. Reagan, J. Gupte, H. Baribault, T. Gyuris, and et al. Elucidation of signaling and functional activities of an orphan GPCR, GPR81 J Lipid Res 49 2008 797 803
19. E.C. Graff, O.C. Norris, M. Sandey, R.J. Kemppainen, and R.L. Judd Characterization of the hydroxycarboxylic acid receptor 2 in cats Domest Anim Endocrinol 53 2015 88 94
20. L.A. Carlson Studies on the effect of nicotinic acid on catecholamine stimulated lipolysis in adipose tissue in vitro Acta Med Scand 173 1963 719 722
21. L.A. Carlson, and L. Oro The effect of nicotinic acid on the plasma free fatty acid; demonstration of a metabolic type of sympathicolysis Acta Med Scand 172 1962 641 645
22. M. Thangaraju, G.A. Cresci, K. Liu, S. Ananth, J.P. Gnanaprakasam, D.D. Browning, and et al. GPR109A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon Cancer Res 69 2009 2826 2832
23. A.K. Taggart, J. Kero, X. Gan, T.Q. Cai, K. Cheng, M. Ippolito, and et al. (d)-beta-Hydroxybutyrate inhibits adipocyte lipolysis via the nicotinic acid receptor PUMA-G J Biol Chem 280 2005 26649 26652
24. B. Senior, and L. Loridan Direct regulatory effect of ketones on lipolysis and on glucose concentrations in man Nature 219 1968 83 84
25. A. Gille, E.T. Bodor, K. Ahmed, and S. Offermanns Nicotinic acid: pharmacological effects and mechanisms of action Annu Rev Pharmacol Toxicol 48 2008 79 106
26. S. Offermanns The nicotinic acid receptor GPR109A (HM74A or PUMA-G) as a new therapeutic target Trends Pharmacol Sci 27 2006 384 390
27. D.R. Donohoe, N. Garge, X. Zhang, W. Sun, T.M. O'Connell, M.K. Bunger, and et al. The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon Cell Metab 13 2011 517 526
28. Z. Gao, J. Yin, J. Zhang, R.E. Ward, R.J. Martin, M. Lefevre, and et al. Butyrate improves insulin sensitivity and increases energy expenditure in mice Diabetes 58 2009 1509 1517
29. R.B. Canani, M.D. Costanzo, L. Leone, M. Pedata, R. Meli, and A. Calignano Potential beneficial effects of butyrate in intestinal and extraintestinal diseases World J Gastroenterol 17 2011 1519 1528
30. N. Singh, A. Gurav, S. Sivaprakasam, E. Brady, R. Padia, H. Shi, and et al. Activation of the receptor (Gpr109a) for niacin and the commensal metabolite butyrate suppresses colonic inflammation and carcinogenesis Immunity 40 2014 128 139
31. O. Bobileva, R. Bokaldere, V. Gailite, I. Kaula, M. Ikaunieks, G. Duburs, and et al. Synthesis and evaluation of (E)-2-(acrylamido)cyclohex-1-enecarboxylic acid derivatives as HCA1, HCA2, and HCA3 receptor agonists Bioorg Med Chem 22 2014 3654 3669
32. R. Altschul, A. Hoffer, and J.D. Stephen Influence of nicotinic acid on serum cholesterol in man Arch Biochem Biophys 54 1955 558 559
33. W.Y. Kwon, G.J. Suh, K.S. Kim, and Y.H. Kwak Niacin attenuates lung inflammation and improves survival during sepsis by downregulating the nuclear factor-kappaB pathway Crit Care Med 39 2011 328 334
34. K.H. Cho, H.J. Kim, B. Rodriguez-Iturbe, and N.D. Vaziri Niacin ameliorates oxidative stress, inflammation, proteinuria, and hypertension in rats with chronic renal failure Am J Physiol Renal Physiol 297 2009 F106 F113
35. R.J. Fox, D.H. Miller, J.T. Phillips, M. Hutchinson, E. Havrdova, M. Kita, and et al. Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis N Engl J Med 367 2012 1087 1097
36. S.P. Fu, S.N. Li, J.F. Wang, Y. Li, S.S. Xie, W.J. Xue, and et al. BHBA suppresses LPS-induced inflammation in BV-2 cells by inhibiting NF-kappaB activation Mediators Inflamm 2014 2014 983401
37. Y.H. Youm, K.Y. Nguyen, R.W. Grant, E.L. Goldberg, M. Bodogai, D. Kim, and et al. The ketone metabolite beta-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease Nat Med 21 2015 263 269
38. J.E. Digby, F. Martinez, A. Jefferson, N. Ruparelia, J. Chai, M. Wamil, and et al. Anti-inflammatory effects of nicotinic acid in human monocytes are mediated by GPR109A dependent mechanisms Arterioscler Thromb Vasc Biol 32 2012 669 676
39. J.E. Digby, E. McNeill, O.J. Dyar, V. Lam, D.R. Greaves, and R.P. Choudhury Anti-inflammatory effects of nicotinic acid in adipocytes demonstrated by suppression of fractalkine, RANTES, and MCP-1 and upregulation of adiponectin Atherosclerosis 209 2010 89 95
40. K.J. Moore, and I. Tabas Macrophages in the pathogenesis of atherosclerosis Cell 145 2011 341 355
41. J.W. van der Hoorn, W. de Haan, J.F. Berbee, L.M. Havekes, J.W. Jukema, P.C. Rensen, and et al. Niacin increases HDL by reducing hepatic expression and plasma levels of cholesteryl ester transfer protein in APOE∗3Leiden·CETP mice Arterioscler Thromb Vasc Biol 28 2008 2016 2022
42. B. Lauring, A.K. Taggart, J.R. Tata, R. Dunbar, L. Caro, K. Cheng, and et al. Niacin lipid efficacy is independent of both the niacin receptor GPR109A and free fatty acid suppression Sci Transl Med 4 2012 148ra15
43. B.J. Wu, K. Chen, P.J. Barter, and K.A. Rye Niacin inhibits vascular inflammation via the induction of heme oxygenase-1 Circulation 125 2012 150 158
44. B.J. Wu, L. Yan, F. Charlton, P. Witting, P.J. Barter, and K.A. Rye Evidence that niacin inhibits acute vascular inflammation and improves endothelial dysfunction independent of changes in plasma lipids Arterioscler Thromb Vasc Biol 30 2010 968 975
45. N. Ruparelia, J.E. Digby, and R.P. Choudhury Effects of niacin on atherosclerosis and vascular function Curr Opin Cardiol 26 2011 66 70
46. K. Zandi-Nejad, A. Takakura, M. Jurewicz, A.K. Chandraker, S. Offermanns, D. Mount, and et al. The role of HCA2 (GPR109A) in regulating macrophage function FASEB J 27 2013 4366 4374
47. E.P. Plaisance, M. Lukasova, S. Offermanns, Y. Zhang, G. Cao, and R.L. Judd Niacin stimulates adiponectin secretion through the GPR109A receptor Am J Physiol Endocrinol Metab 296 2009 E549 E558
48. G. Fraterrigo, E. Fabbrini, B. Mittendorfer, S. O'Rahilly, P.E. Scherer, B.W. Patterson, and et al. Relationship between changes in plasma adiponectin concentration and insulin sensitivity after niacin therapy Cardiorenal Med 2 2012 211 217
49. M. Hu, Y.L. Yang, D. Masuda, S. Yamashita, and B. Tomlinson Effect of extended-release niacin/laropiprant combination on plasma adiponectin and insulin resistance in Chinese patients with dyslipidaemia Dis Markers 2015 2015 154014
50. G. Deng, Y. Long, Y.R. Yu, and M.R. Li Adiponectin directly improves endothelial dysfunction in obese rats through the AMPK-eNOS Pathway Int J Obes (Lond) 34 2010 165 171
51. Y. Arita, S. Kihara, N. Ouchi, K. Maeda, H. Kuriyama, Y. Okamoto, and et al. Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell Circulation 105 2002 2893 2898
52. N. Ouchi, S. Kihara, Y. Arita, M. Nishida, A. Matsuyama, Y. Okamoto, and et al. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages Circulation 103 2001 1057 1063
53. N. Ouchi, S. Kihara, Y. Arita, K. Maeda, H. Kuriyama, Y. Okamoto, and et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin Circulation 100 1999 2473 2476
54. E.J. Folco, V.Z. Rocha, M. Lopez-Ilasaca, and P. Libby Adiponectin inhibits pro-inflammatory signaling in human macrophages independent of interleukin-10 J Biol Chem 284 2009 25569 25575
55. B.B. Kahn, and J.S. Flier Obesity and insulin resistance J Clin Invest 106 2000 473 481
56. H. Prasad, D.A. Ryan, M.F. Celzo, and D. Stapleton Metabolic syndrome: definition and therapeutic implications Postgrad Med 124 2012 21 30
57. N. Halberg, I. Wernstedt-Asterholm, and P.E. Scherer The adipocyte as an endocrine cell Endocrinol Metab Clin North Am 37 2008 753 768
58. K. Hotta, T. Funahashi, N.L. Bodkin, H.K. Ortmeyer, Y. Arita, B.C. Hansen, and et al. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys Diabetes 50 2001 1126 1133
59. M.E. Trujillo, and P.E. Scherer Adiponectin - journey from an adipocyte secretory protein to biomarker of the metabolic syndrome J Intern Med 257 2005 167 175
60. S.P. Weisberg, D. McCann, M. Desai, M. Rosenbaum, R.L. Leibel, and A.W. Ferrante Obesity is associated with macrophage accumulation in adipose tissue J Clin Invest 112 2003 1796 1808
61. A.A. Hill, W. Reid Bolus, and A.H. Hasty A decade of progress in adipose tissue macrophage biology Immunol Rev 262 2014 134 152
62. C.N. Lumeng, J.L. Bodzin, and A.R. Saltiel Obesity induces a phenotypic switch in adipose tissue macrophage polarization J Clin Invest 117 2007 175 184
63. N. Ouchi, and K. Walsh Adiponectin as an anti-inflammatory factor Clin Chim Acta 380 2007 24 30
64. B. Pyrzak, M. Ruminska, K. Popko, and U. Demkow Adiponectin as a biomarker of the metabolic syndrome in children and adolescents Eur J Med Res 15 2010 147 151
65. E.P. Plaisance, P.W. Grandjean, B.L. Brunson, and R.L. Judd Increased total and high-molecular weight adiponectin after extended-release niacin Metabolism 57 2008 404 409
66. P. Mandal, B.T. Pratt, M. Barnes, M.R. McMullen, and L.E. Nagy Molecular mechanism for adiponectin-dependent M2 macrophage polarization: link between the metabolic and innate immune activity of full-length adiponectin J Biol Chem 286 2011 13460 13469
67. N. Ouchi, S. Kihara, Y. Arita, Y. Okamoto, K. Maeda, H. Kuriyama, and et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway Circulation 102 2000 1296 1301
68. D. Wanders, E.C. Graff, and R.L. Judd Effects of high fat diet on GPR109A and GPR81 gene expression Biochem Biophys Res Commun 425 2012 278 283
69. J.T. Chai, J.E. Digby, N. Ruparelia, A. Jefferson, A. Handa, and R.P. Choudhury Nicotinic acid receptor GPR109A is down-regulated in human macrophage-derived foam cells PLoS One 8 2013 e62934
70. K.R. Feingold, A. Moser, J.K. Shigenaga, and C. Grunfeld Inflammation stimulates niacin receptor (GPR109A/HCA2) expression in adipose tissue and macrophages J Lipid Res 55 2014 2501 2508
71. C. Jobin GPR109a: the missing link between microbiome and good health? Immunity 40 2014 8 10
72. H.M. Hamer, D. Jonkers, K. Venema, S. Vanhoutvin, F.J. Troost, and R.J. Brummer Review article: the role of butyrate on colonic function Aliment Pharmacol Ther 27 2008 104 119
73. J.R. Guzman, V.S. Conlin, and C. Jobin Diet, microbiome, and the intestinal epithelium: an essential triumvirate? Biomed Res Int 2013 10.1155/2013/425146
74. J.R. Davie Inhibition of histone deacetylase activity by butyrate J Nutr 133 2003 2485S 2493S
75. P.V. Chang, L. Hao, S. Offermanns, and R. Medzhitov The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition Proc Natl Acad Sci U S A 111 2014 2247 2252
76. L. Macia, J. Tan, A.T. Vieira, K. Leach, D. Stanley, S. Luong, and et al. Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome Nat Commun 6 2015 1 15
77. M.M. Nentwich, and M.W. Ulbig Diabetic retinopathy - ocular complications of diabetes mellitus World J Diabetes 6 2015 489 499
78. F. Bandello, R. Lattanzio, I. Zucchiatti, and C. Del Turco Pathophysiology and treatment of diabetic retinopathy Acta Diabetol 50 2013 1 20
79. N. Bhagat, R.A. Grigorian, A. Tutela, and M.A. Zarbin Diabetic macular edema: pathogenesis and treatment Surv Ophthalmol 54 2009 1 32
80. A.M. Joussen, T. Murata, A. Tsujikawa, B. Kirchhof, S.E. Bursell, and A.P. Adamis Leukocyte-mediated endothelial cell injury and death in the diabetic retina Am J Pathol 158 2001 147 152
81. P.M. Martin, S. Ananth, G. Cresci, P. Roon, S. Smith, and V. Ganapathy Expression and localization of GPR109A (PUMA-G/HM74A) mRNA and protein in mammalian retinal pigment epithelium Mol Vis 15 2009 362 372
82. A.L. Yu, K. Birke, R.L. Lorenz, and U. Welge-Lussen Constitutive expression of HCA(2) in human retina and primary human retinal pigment epithelial cells Curr Eye Res 39 2014 487 492
83. B. Detrick, and J.J. Hooks Immune regulation in the retina Immunol Res 47 2010 153 161
84. W. Promsote, R. Veeranan-Karmegam, S. Ananth, D. Shen, C.C. Chan, N.A. Lambert, and et al. l-2-Oxothiazolidine-4-carboxylic acid attenuates oxidative stress and inflammation in retinal pigment epithelium Mol Vis 20 2014 73 88
85. N. Dupuis, N. Curatolo, J.F. Benoist, and S. Auvin Ketogenic diet exhibits anti-inflammatory properties Epilepsia 56 2015 e95 e98
86. A. Tolaymat, A. Nayak, J.D. Geyer, S.K. Geyer, and P.R. Carney Diagnosis and management of childhood epilepsy Curr Probl Pediatr Adolesc Health Care 45 2015 3 17
87. Y. Kashiwaya, C. Bergman, J.-H. Lee, R. Wan, M.T. King, M.R. Mughal, and et al. A ketone ester diet exhibits anxiolytic and cognition-sparing properties, and lessens amyloid and tau pathologies in a mouse model of Alzheimer's disease Neurobiol Aging 34 2013 1530 1539
88. I. Van der Auwera, S. Wera, F. Van Leuven, and S.T. Henderson A ketogenic diet reduces amyloid beta 40 and 42 in a mouse model of Alzheimer's disease Nutr Metab (Lond) 2 2005 28 36
89. Z. Zhao, D.J. Lange, A. Voustianiouk, D. MacGrogan, L. Ho, J. Suh, and et al. A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis BMC Neurosci 7 2006 1 10
90. S. Lim, A.S. Chesser, J.C. Grima, P.M. Rappold, D. Blum, S. Przedborski, and et al. d-β-Hydroxybutyrate is protective in mouse models of Huntington's disease PLoS One 6 2011 e24620
91. K. Tieu, C. Perier, C. Caspersen, P. Teismann, D.C. Wu, S.D. Yan, and et al. d-beta-Hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease J Clin Invest 112 2003 892 901
92. T.B. Vanitallie, C. Nonas, A. Di Rocco, K. Boyar, K. Hyams, and S.B. Heymsfield Treatment of Parkinson disease with diet-induced hyperketonemia: a feasibility study Neurology 64 2005 728 730
93. Y. Kim do, J. Hao, R. Liu, G. Turner, F.D. Shi, and J.M. Rho Inflammation-mediated memory dysfunction and effects of a ketogenic diet in a murine model of multiple sclerosis PLoS One 7 2012 e35476
94. M.A. Puchowicz, J.L. Zechel, J. Valerio, D.S. Emancipator, K. Xu, S. Pundik, and et al. Neuroprotection in diet-induced ketotic rat brain after focal ischemia J Cereb Blood Flow Metab 28 2008 1907 1916
95. Z.G. Hu, H.D. Wang, L. Qiao, W. Yan, Q.F. Tan, and H.X. Yin The protective effect of the ketogenic diet on traumatic brain injury-induced cell death in juvenile rats Brain Inj 23 2009 459 465
96. B. Cheng, X. Yang, L. An, B. Gao, X. Liu, and S. Liu Ketogenic diet protects dopaminergic neurons against 6-OHDA neurotoxicity via up-regulating glutathione in a rat model of Parkinson's disease Brain Res 1286 2009 25 31
97. X. Yang, and B. Cheng Neuroprotective and anti-inflammatory activities of ketogenic diet on MPTP-induced neurotoxicity J Mol Neurosci 42 2010 145 153
98. S.P. Fu, J.F. Wang, W.J. Xue, H.M. Liu, B.R. Liu, Y.L. Zeng, and et al. Anti-inflammatory effects of BHBA in both in vivo and in vitro Parkinson disease models are mediated by GPR109A-dependent mechanisms J Neuroinflammation 12 2015 1 14
99. M. Suzuki, M. Suzuki, Y. Kitamura, S. Mori, K. Sato, S. Dohi, and et al. beta-Hydroxybutyrate, a cerebral function improving agent, protects rat brain against ischemic damage caused by permanent and transient focal cerebral ischemia Jpn J Pharmacol 89 2002 36 43
100. H. Chen, J.C. Assmann, A. Krenz, M. Rahman, M. Grimm, C.M. Karsten, and et al. Hydroxycarboxylic acid receptor 2 mediates dimethyl fumarate's protective effect in EAE J Clin Invest 124 2014 2188 2192
101. B. Parodi, S. Rossi, S. Morando, C. Cordano, A. Bragoni, C. Motta, and et al. Fumarates modulate microglia activation through a novel HCAR2 signaling pathway and rescue synaptic dysregulation in inflamed CNS Acta Neuropathol 30 2015 279 295
102. S. Offermanns, and M. Schwaninger Nutritional or pharmacological activation of HCA ameliorates neuroinflammation Trends Mol Med 21 2015 245 255
103. Y. Masuda, Y. Ochi, Y. Ochi, T. Karasawa, N. Hatano, T. Kadokawa, and et al. Protective effect of prostaglandins D2, E1 and I2 against cerebral hypoxia/anoxia in mice Naunyn Schmiedebergs Arch Pharmacol 334 1986 282 289
104. H. Taniguchi, I. Mohri, H. Okabe-Arahori, K. Aritake, K. Wada, T. Kanekiyo, and et al. Prostaglandin D2 protects neonatal mouse brain from hypoxic ischemic injury J Neurosci 27 2007 4303 4312
105. X. Zhao, R. Strong, J. Zhang, G. Sun, J.Z. Tsien, Z. Cui, and et al. Neuronal PPARgamma deficiency increases susceptibility to brain damage after cerebral ischemia J Neurosci 29 2009 6186 6195
106. E.H. Kim, and Y.J. Surh The role of 15-deoxy-delta(12,14)-prostaglandin J(2), an endogenous ligand of peroxisome proliferator-activated receptor gamma, in tumor angiogenesis Biochem Pharmacol 76 2008 1544 1553
107. E.Z. Chai, K.S. Siveen, M.K. Shanmugam, F. Arfuso, and G. Sethi Analysis of the intricate relationship between chronic inflammation and cancer Biochem J 468 2015 1 15
108. R. Hoque, and W.Z. Mehal Inflammasomes in pancreatic physiology and disease Am J Physiol Gastrointest Liver Physiol 308 2015 G643 G651
109. L. Chen, W.Y. So, S.Y. Li, Q. Cheng, B.J. Boucher, and P.S. Leung Niacin-induced hyperglycemia is partially mediated via niacin receptor GPR109a in pancreatic islets Mol Cell Endocrinol 404 2015 56 66
110. D.E. Weiner Causes and consequences of chronic kidney disease: implications for managed health care J Manag Care Pharm 13 2007 S1 S9
111. K.H. Cho, H.J. Kim, V.S. Kamanna, and N.D. Vaziri Niacin improves renal lipid metabolism and slows progression in chronic kidney disease Biochim Biophys Acta 2010 1800 6 15
112. A.G. Bostom, A.A. Maclean, D. Maccubbin, D. Tipping, H. Giezek, and W.A. Hanlon Extended-release niacin/laropiprant lowers serum phosphorus concentrations in patients with type 2 diabetes J Clin Lipidol 5 2011 281 287
113. D. Maccubbin, D. Tipping, O. Kuznetsova, W.A. Hanlon, and A.G. Bostom Hypophosphatemic effect of niacin in patients without renal failure: a randomized trial Clin J Am Soc Nephrol 5 2010 582 589
114. G. Gurujeyalakshmi, Y. Wang, and S.N. Giri Taurine and niacin block lung injury and fibrosis by down-regulating bleomycin-induced activation of transcription nuclear factor-kappaB in mice J Pharmacol Exp Ther 293 2000 82 90
115. J. Hanson, A. Gille, and S. Offermanns Role of HCA2 (GPR109A) in nicotinic acid and fumaric acid ester-induced effects on the skin Pharmacol Ther 136 2012 1 7
116. I. Helwa, R. Patel, P. Karempelis, I. Kaddour-Djebbar, V. Choudhary, and W.B. Bollag The antipsoriatic agent monomethylfumarate has antiproliferative, prodifferentiative, and anti-inflammatory effects on keratinocytes J Pharmacol Exp Ther 352 2015 90 97
117. F. Nantel, D. Denis, R. Gordon, A. Northey, M. Cirino, K.M. Metters, and et al. Distribution and regulation of cyclooxygenase-2 in carrageenan-induced inflammation Br J Pharmacol 128 1999 853 859
118. S. Hammarstrom, M. Hamberg, B. Samuelsson, E.A. Duell, M. Stawiski, and J.J. Voorhees Increased concentrations of nonesterified arachidonic acid, 12-l-hydroxy-5,8,10,14-eicosatetraenoic acid, prostaglandin E2, and prostaglandin F2alpha in epidermis of psoriasis Proc Natl Acad Sci U S A 72 1975 5130 5134
119. D.M. Reilly, R. Parslew, G.R. Sharpe, S. Powell, and M.R. Green Inflammatory mediators in normal, sensitive and diseased skin types Acta Derm Venereol 80 2000 171 174